SEC Form 4 · accession 0001162194-15-000118
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Maxwell Smith
Officer — EVP, LEGAL AFFAIRS & GC
Period of report
Jun 15, 2015
Accepted (ET)
Jun 17, 2015 · 6:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 15, 2015 | M | 947 | $8.3732 | A | 2,336 | D | |
| Common Stock | Jun 15, 2015 | M | 2,053 | $8.3732 | A | 4,389 | D | |
| Common Stock | Jun 15, 2015 | S | 3,000 | $24.20 | D | 1,389 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $8.3732 | Jun 15, 2015 | M | 947 | D | — | Jan 4, 2021 | Common Stock | 947 | 0 | D |
| Employee Stock Option (Right to Buy)F2 | $8.3732 | Jun 15, 2015 | M | 2,053 | D | — | Jan 4, 2021 | Common Stock | 2,053 | 3,727 | D |
Explanation of responses
- F1The sales reported by Mr. Smith were effected pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2014.
- F2The shares subject to the Option fully vested on April 1, 2014.